At the symposium renowned speakers from the fields of science and business will investigate topics, such as biomarkers, biobanking, sample archival, personalized medicine and monitoring from a holistic perspective.
At 10:30am, Mark Adler, MD, Chairman of SAB, will present clinical perspectives on treatment response monitoring using Biological Dynamics technology.
Biological Dynamics is a private molecular diagnostics company located in San Diego. Our proprietary technology offers a novel, fast, and cost-effective lab-on-chip ACE platform that isolates nanoparticles from high conductance physiological solutions.
Our product, the TR(ACE)™ assay, will utilize the platform for monitoring treatment response in oncology. TR(ACE)™ has not been cleared or approved by the U.S. FDA or any foreign regulatory agency.
